Loxo Oncology
Utility Patents

Last updated:

List of all Loxo Oncology patents 20 in total

Status Patent
Grant
Utility: Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrim- idin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof External link
Filling date: 6 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Methods of treating pediatric cancers External link
Filling date: 6 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bontrile External link
Filling date: 6 Sep 2025 Issue date: 24 Aug 2021
Grant
Utility: Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Compounds useful as kinase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 16 Feb 2021
Grant
Utility: Point mutations in TRK inhibitor-resistant cancer and methods relating to the same External link
Filling date: 6 Sep 2025 Issue date: 2 Feb 2021
Grant
Utility: Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-- diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carb- onitrile External link
Filling date: 6 Sep 2025 Issue date: 29 Sep 2020
Grant
Utility: Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bonitrile External link
Filling date: 6 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Point mutations in TRK inhibitor-resistant cancer and methods relating to the same External link
Filling date: 6 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Compounds useful as kinase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyri- midin-3-yl)-3-hydroxypyrrolidine-1-carboxamide External link
Filling date: 6 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Point mutations in TRK inhibitor-resistant cancer and methods relating to the same External link
Filling date: 6 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer External link
Filling date: 6 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: Methods of treating pediatric cancers External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase External link
Filling date: 6 Sep 2025 Issue date: 21 Jan 2020
Grant
Utility: Compounds useful as kinase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Point mutations in TRK inhibitor-resistant cancer and methods relating to the same External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2019
Grant
Utility: Point mutations in TRK inhibitor-resistant cancer and methods relating to the same External link
Filling date: 6 Sep 2025 Issue date: 6 Aug 2019

Showing 1 to 20 of 20 patents.